Preserve Access to Affordable Generics and Biosimilars Act

United States117e CongrèsHR-2891House of Representatives
Mis à jour : 29 sept. 2021

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Introduced (House)Consulter le texte officiel

1 version disponible

Tous les dossiers disponibles sont affichés.

Chronologie

Dernière mesure du projet de loi complémentaire

S-1428: Preserve Access to Affordable Generics and Biosimilars Act

Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

  1. Introduced in House

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Committee Consideration and Mark-up Session Held.

    House of Representatives

  4. Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.

    House of Representatives